OSAHS患者个性化治疗

陈雄; 孔维佳

doi:10.13201/j.issn.1001-1781.2016.06.004

OSAHS患者个性化治疗

陈雄^,,
孔维佳

- 华中科技大学同济医学院附属协和医院耳鼻咽喉科(武汉, 430022)

详细信息

通讯作者: 陈雄,E-mail:chenxiong1015@aliyun.com

中图分类号: R563.8

收稿日期: 2016-01-25

Individualized threatment of patients with obstructive sleep apea-hypopnea syndrome

CHEN Xiong^,,
KONG Weijia

More Information

Corresponding author: CHEN Xiong, E-mail: chenxiong1015@aliyun.com

Received Date: 25 January 2016

摘要

- 睡眠呼吸暂停低通气综合征 /
- 阻塞性 /
- OSA表型特征 /
- 个性化治疗 /
- 精准医疗
Abstract: Obstructive sleep apnea-hypopnea syndrome(OSAHS)is a kind of disease with a complex etiology,a high incidence and a wide variety of therapeutic methods.as a first-line treatment of OSAHS,non-invasive continuous positive airway pressure(CPAP)encounters the problem of low compliance of theray.And other methods of treatment are all required to meet the strict of indications to obtain the effect of therapy.The large individual anatomical differences and the great variability of non anatomical factors of the upper airway stucture of OSAHS patients,determine the diversity of OSAHS treatment.The personalized therapy is an inevitable trend in the future.in this paper,the pathogenesis,treatment methods,treatment status and personalized diagnosis and treatment trends are summarized and discussed briefly in this paper.
- sleep apnea hypopnea syndrome /
- obstructive /
- OSA phenotypic traits /
- personalized therapy /
- precise medical treatment

HTML全文

参考文献(28)

[1]	PEPPARD P E,YOUNG T,BARNET J H,et al.Increased prevalence of sleep-disordered breathing in adults[J].Am J Epidemiol,2013,177:1006-1014.
[2]	SFORZA E.Pharyngeal critical pressure in patients with obstructive sleep apnea syndrome:clinical implications[J].Am J Respir Crit Care Med,1999,159:149-157.
[3]	WEAVER TE,CALIK M W,FARABI S S,et al.Innovative treatments for adults with obstructive sleep apnea[J].Nat Sci Sleep,2014,6:137-147.
[4]	WELLMAN A,JORDAN A S,MALHOTRA A,et al.Ventilatory control and airway anatomy in obstructive sleep apnea[J].Am J Respir Crit Care Med,2004,170:11-11.
[5]	YOUNES M,OSTROWSKI M,THOMPSON W,et al.Chemical control stability in patients with obstructive sleep apnea[J].Am J Respir Crit Care Med,2001,163:1181-1190.
[6]	WELLMAN A,ECKERT D J,JORDAN A S,et al.A method for measuring and modeling the physiological traits causing obstructive sleep apnea[J].J Appl Physiol,2011,110:1627-1637.
[7]	KIWULL-SCHONE H,TEPPEMA L,WIEMANNM,et al.Loop gain of respiratory control upon reduced activity of carbonic anhydrase or Na+/H+exchange[J].Adv Exp Med Biol,2006,580:239-244,351-239.
[8]	LUU V.The pathogenesis of obstructive sleep apnea[J].J Thorac Dis,2015,7:1358-1372.
[9]	EDWARDS B A,CONNOLLY J G.Acetazolamide attenuates the ventilator response to arousal in patients with obstructive sleep apnea[J].Sleep,2013,36:281-285.
[10]	SCHRODER C M,PRIMEAU M M,HALLMAYERJ F,et al.Serotonin transporter polymorphism is associated with increased apnea-hypopnea index in older adults[J].Int J Geriatr Psychiatry,2014,29:227-235.
[11]	SHIRANI A,PARADISO S,DYKEN M E.The impact of atypical antipsychotic use on obstructive sleep apnea:apilot study and literature review[J].Sleep Med,2011,12:591-597.
[12]	ECKERT D J,OWENS R L,KEHLMANN G B,et al.Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousalthreshold[J].Clin Sci(Lond),2011,120:505-514.
[13]	KUSHIDA C A,CHEDIAK A,BERRY R B,et al.Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea[J].J Clin Sleep Med,2008,4:157-171.
[14]	SUTHERLAND K,VANDERVEKEN O M,TSU-DA H,et al.Oral appliance treatment for obstructive sleep apnea:an update[J].J Clin Sleep Med,2014,10:215-227.
[15]	PARK J G,MORGENTHALER T M,GAY P C.Novel and emerging nonpositive airway pressure therapies for sleep apnea[J].Chest,2013,144:1946-1952.
[16]	WALSH J K,GRIFFIN K S,FORST E H,et al.Aconvenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients nonadherent with continuous positive airway pressure[J].Sleep Med,2011,12:147-152.
[17]	KUHLO W,DOLL E,FRANCK M C.Successful management of Pickwickian syndrome using long-term tracheostomy[J].Dtsch Med Wochenschr,1969,94:1286-1290.
[18]	MARIELLE J,BULT F.Surgical treatment of obesity[J].European J Endocrinol,2008,158:135-145.
[19]	ZOU J,ZHANG P,YU H,et al.Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea in a Chinese Population with Obesity and T2DM[J].Obes Surg,2015,,25:1446-1453.
[20]	GOESSLER U R,HEIN G,VERSTE T,et al.Soft palate implants as a minimally invasive treatment for mild to moderate obstructive sleep apnea[J].Acta Otolaryngol,2007,127:527-531.
[21]	STROLLO P J JR,SOOSE R J,MAURER J T,et al.Upper-airway stimulation for obstructive sleep apnea[J].N Engl J Med,2014,370:139-149.
[22]	BETTEGA G,PEPIN J L.Obstructive sleep apnea syndrome.fifty-one consecutive patients treated by maxillofacial surgery[J].Am J Respir Crit Care Med,2000,162:641-649.
[23]	RACHMIEL A,EMODI O,AIZENBUD D.Management of obstructive sleep apnea in pediatric craniofacial anomalies[J].Ann Maxillofac Surg,2012,2:111-115.
[24]	BOYD S B,WALTERS A S,WAITE P,et al.LongTerm effectiveness and safety of maxillomandibular advancement for treatment of obstructive sleep apnea[J].J Clin Sleep Med,2015,11:699-708.
[25]	CAMACHO M,RIAZ M,CAPASSO R,et al.The effect of nasal surgery on continuous positive airway pressure device use and therapeutic treatment pressures:a systematic review and meta-analysis[J].Sleep,2015,38:279-286.
[26]	MARCUS C L,BROOKS L J,DRAPER K A,et al.Diagnosis and management of childhood obstructive sleep apnea syndrome[J].Pediatrics,2012,130,e714-e714.
[27]	WIMMS A J,RICHARDS G N,BENJAFIELD A V.Assessment of the impact on compliance of a new CPAP system in obstructive sleep apnea[J].Sleep Breath,2013,17:69-76.
[28]	WEAVER T E,GRUNSTEIN R R.Adherence to continuous positive airway pressure therapy:the challenge to effective treatment[J].Proc Am Thorac Soc,2008,15:173-178.